Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.42B |
| 2 |
Vale
VALE
|
+$1.05B |
| 3 |
Freeport-McMoran
FCX
|
+$988M |
| 4 |
Micron Technology
MU
|
+$690M |
| 5 |
ExxonMobil
XOM
|
+$534M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.21B |
| 2 |
TC Energy
TRP
|
+$1.37B |
| 3 |
Microsoft
MSFT
|
+$1.32B |
| 4 |
Verizon
VZ
|
+$1.31B |
| 5 |
Amazon
AMZN
|
+$940M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 16.54% |
| 3 | Communication Services | 12.92% |
| 4 | Consumer Discretionary | 12.55% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Kroger
KR
$34.3B
| $216M | 0.07% |
8,765,884
-3
| -0% | -$82 |
|
202
ATI
ATI
$31.4B
| $213M | 0.07% |
8,332,140
-531,840
| -6% | -$14M |
|
203
GE Aerospace
GE
$379B
| $211M | 0.07% |
4,238,661
-2,474,299
| -37% | -$116M |
|
204
Petrobras Class A
PBR.A
$103B
| $211M | 0.07% |
14,724,242
-5,858,630
| -28% | -$82M |
|
205
Madrigal Pharmaceuticals
MDGL
$12.4B
| $208M | 0.07% |
1,664,452
| – | – |
|
206
Webster Financial
WBS
$12.8B
| $208M | 0.07% |
4,106,174
+141,509
| +4% | +$7.67M |
|
207
Valvoline
VVV
$4.25B
| $201M | 0.06% |
10,824,437
+150,315
| +1% | +$2.98M |
|
208
Intuit
INTU
$91.6B
| $200M | 0.06% |
765,226
+209,602
| +38% | +$48.4M |
|
209
Nasdaq
NDAQ
$53.5B
| $197M | 0.06% |
+6,762,213
| New | +$193M |
|
210
East-West Bancorp
EWBC
$18.5B
| $194M | 0.06% |
4,053,988
+300,384
| +8% | +$15.3M |
|
211
Telus
TU
$15B
| $191M | 0.06% |
10,321,388
+584
| +0% | +$10.3K |
|
|
MGP
212
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $190M | 0.06% |
5,898,200
+647,000
| +12% | +$19.6M |
|
|
AZUL
213
DELISTED
Azul
AZUL
| $189M | 0.06% |
6,476,183
-14,956
| -0.2% | -$447K |
|
214
Xcel Energy
XEL
$49.1B
| $189M | 0.06% |
3,365,143
-17
| -0% | -$904 |
|
215
Danaher
DHR
$145B
| $178M | 0.06% |
1,523,410
-563,991
| -27% | -$57.8M |
|
216
Kraft Heinz
KHC
$29.1B
| $178M | 0.06% |
5,439,711
-3,828,271
| -41% | -$156M |
|
217
Lam Research
LRCX
$408B
| $177M | 0.06% |
9,907,850
-1,399,370
| -12% | -$23.3M |
|
218
Dine Brands
DIN
$462M
| $176M | 0.06% |
1,924,257
+312
| +0% | +$26.5K |
|
219
Ecolab
ECL
$78.1B
| $175M | 0.06% |
991,311
| – | – |
|
220
Five Below
FIVE
$13.2B
| $174M | 0.06% |
1,403,902
-185,500
| -12% | -$22.5M |
|
|
CBPO
221
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $174M | 0.06% |
1,901,400
-185,948
| -9% | -$15.2M |
|
|
ALLK
222
DELISTED
Allakos
ALLK
| $170M | 0.05% |
4,192,597
+706,129
| +20% | +$28.5M |
|
223
NiSource
NI
$20.1B
| $170M | 0.05% |
5,921,178
+1,117
| +0% | +$30.1K |
|
|
TMX
224
DELISTED
Terminix Global Holdings, Inc.
TMX
| $163M | 0.05% |
3,482,250
+226,000
| +7% | +$9.45M |
|
225
Comcast
CMCSA
$90.4B
| $162M | 0.05% |
4,046,440
-1,907
| -0% | -$71.8K |
|
Similar funds
Capital Research Global Investors's Q1 2019 Portfolio in Review
As of Q1 2019, Capital Research Global Investors held 442 positions worth $315B, up 9.9% from $287B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q1 2019 filing shows 25 new, 151 increased, 166 reduced and 27 closed positions. Its largest new stake was Micron Technology: 17,867,672 shares worth $738M. The largest sale was AbbVie, an estimated $2.21B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q1 2019 buy was Micron Technology: 17,867,672 shares worth $738M.
- Capital Research Global Investors added most to Alibaba in Q1 2019, an estimated $1.42B increase.
- Capital Research Global Investors's biggest Q1 2019 reduction was AbbVie, cutting an estimated $2.21B.
- Capital Research Global Investors fully exited TC Energy in Q1 2019, selling an estimated $1.37B.
- Capital Research Global Investors's ten largest holdings make up 27% of its $315B portfolio in Q1 2019.
- Capital Research Global Investors opened 25 new positions and closed 27 in Q1 2019.
- Capital Research Global Investors's portfolio value rose 9.9% quarter-over-quarter to $315B.
Based on Capital Research Global Investors's 13F filing for Q1 2019, filed 15 May 2019.